Gene Therapy for DME
NCT06492876
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
78
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
GENETIC:
FT-003
Sponsor
Frontera Therapeutics